Product Liability
Apr. 29, 2006
Drug Company to Pay $500 Million for Making Misleading Claim
SAN FRANCISCO - A pharmaceutical giant has agreed to pay nearly $500 million to settle false advertising claims involving a cold sore remedy that promised to "cut healing time in half," under a settlement approved Wednesday in San Francisco Superior Court.
Daily Journal Staff Writer
A pharmaceutical giant has agreed to pay nearly $500 million to settle false advertising claims involving a cold sore remedy that promised to "cut healing time in half," under a settlement approved Wednesday in San Francisco Superior Court.
GlaxoSmithKline, which produces the cold sore product Abreva, will offer $475 milli...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In